Long‐term outcomes of melody valve‐in‐valve implantation for bioprosthetic mitral valve dysfunction

2018 ◽  
Vol 93 (6) ◽  
pp. 1087-1094 ◽  
Author(s):  
Timothy A. Joseph ◽  
Mackram F. Eleid ◽  
Allison K. Cabalka ◽  
Joseph F. Maalouf ◽  
Charanjit S. Rihal
Keyword(s):  
Mitral Valve ◽  
Long Term Outcomes ◽  
Valve Dysfunction ◽  
Melody Valve ◽  
Valve In Valve ◽  
Valve Implantation ◽  
Bioprosthetic Mitral Valve

scholarly journals Meshalkin National Medical Research Center

2021 ◽  
Vol 26 (8) ◽  
pp. 4565
Author(s):  
A. V. Bogachev-Prokofiev ◽  
R. M. Sharifulin ◽  
D. A. Astapov ◽  
M. A. Ovcharov ◽  
M. A. Ovchinnikova ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Severe Heart Failure ◽  
Cardiac Pacing ◽  
Valve Dysfunction ◽  
Satisfactory Condition ◽  
National Medical ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Bioprosthetic Mitral Valve

We present three cases of successful transatrial transcatheter valve-in-valve implantation in patients with bioprosthetic mitral valve dysfunction. Patients with a high surgical risk, with severe heart failure due to bioprosthetic mitral valve dysfunction, were implanted with transcatheter prostheses using the transatrial approach.Transesophageal echocardiography and fluoroscopy-guided transcatheter mitral prosthetic valve positioning was performed. With a cardiac pacing at 180 bpm, a transcatheter valve was implanted. The transcatheter valves functioned properly after surgery. The patients were discharged in satisfactory condition.

scholarly journals 5-Year Experience With Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve Dysfunction

2013 ◽  
Vol 61 (17) ◽  
pp. 1759-1766 ◽  
Author(s):  
Anson Cheung ◽  
John G. Webb ◽  
Marco Barbanti ◽  
Melanie Freeman ◽  
Ronald K. Binder ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Bioprosthetic Valve ◽  
Valve Dysfunction ◽  
Valve In Valve ◽  
Valve Implantation

scholarly journals Percutaneous Management of Prosthetic Valve Dysfunction in Mitral Position: Transapical Mitral Valve-In-Valve Implantation

2019 ◽  
Vol 87 (5) ◽  
pp. 380-382
Author(s):  
Juan R. Alderete ◽  
Alberto C. Anaya Revolledo ◽  
Verónica I. Volberg ◽  
Miguel Rubio ◽  
Gustavo E. Barrera ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Prosthetic Valve ◽  
Valve Dysfunction ◽  
Prosthetic Valve Dysfunction ◽  
Mitral Position ◽  
Valve In Valve ◽  
Valve Implantation

scholarly journals Immediate results of mitral valve-in-valve implantation for bioprosthetic valve dysfunction

2015 ◽  
Vol 19 (2) ◽  
pp. 36 ◽  
Author(s):  
L. S. Barbarash ◽  
A. N. Stasev ◽  
S. G. Kokorin ◽  
N. V. Rutkovskaya ◽  
I. N. Sizova
Keyword(s):  
Cardiovascular Diseases ◽  
Mitral Valve ◽  
Valve Replacement ◽  
Bioprosthetic Valve ◽  
Advanced Age ◽  
Valve Dysfunction ◽  
Satisfactory Performance ◽  
Hospital Deaths ◽  
Valve In Valve ◽  
Valve Implantation

<p><strong>Background</strong>. Patients with bioprosthetic valve dysfunction have a higher risk for redo procedures because of advanced age, comorbidities and redo-related technical difficulties. Thus, valve-in-valve replacement seems to be an easier and safer option for this group of patients.<br />Objective. To assess the immediate results of mitral valve-in-valve implantation for bioprosthetic valve dysfunction.<br /><strong>Methods</strong>. 6 patients underwent mitral valve-in-valve implantation using “UniLine” prostheses at Kemerovo Research Institute for Complex Problems of Cardiovascular Diseases in 2014.<br /><strong>Results.</strong> There were no cases of in-hospital deaths and prosthesis-related complications in the group under study. Satisfactory performance of bioprostheses was confirmed by echocardiography offered to all the patients before their discharge. <br /><strong>Conclusion.</strong> Mitral valve-in-valve implantation for bioprosthetic valve dysfunction allows achieving satisfactory immediate results.</p>

scholarly journals Bioprosthetic mitral valve replacement in patients aged 65 years or younger: long-term outcomes with the Carpentier–Edwards PERIMOUNT pericardial valve†

2018 ◽  
Vol 54 (2) ◽  
pp. 302-309 ◽  
Author(s):  
Thierry Bourguignon ◽  
Fabien Espitalier ◽  
Clémence Pantaleon ◽  
Emmanuelle Vermes ◽  
Jean Marc El-Arid ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Long Term Outcomes ◽  
Bioprosthetic Mitral Valve

scholarly journals Transvenous, Antegrade Melody Valve-in-Valve Implantation for Bioprosthetic Mitral and Tricuspid Valve Dysfunction

2013 ◽  
Vol 6 (6) ◽  
pp. 598-605 ◽  
Author(s):  
Michael W. Cullen ◽  
Allison K. Cabalka ◽  
Oluseun O. Alli ◽  
Sorin V. Pislaru ◽  
Paul Sorajja ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Valve Dysfunction ◽  
Melody Valve ◽  
Valve In Valve ◽  
Valve Implantation

scholarly journals TCT-802 Long-Term Follow-Up for Complete Transcatheter Melody Valve-in-Valve Implantation for High-Pressure Systemic Bioprosthesis Failure

2014 ◽  
Vol 64 (11) ◽  
pp. B235
Author(s):  
Sean Wilson ◽  
Chad Kliger ◽  
Dillon Weiss ◽  
Vladimir Jelnin ◽  
Ahmed Al-Badri ◽  
...  
Keyword(s):  
High Pressure ◽  
Melody Valve ◽  
Long Term Follow Up ◽  
Valve In Valve ◽  
Valve Implantation

scholarly journals IMMEDIATE AND LONG-TERM OUTCOMES AFTER BIOPROSTHETIC MITRAL VALVE REPLACEMENT WITH THE PRESERVATION OF THE SUBVALVULAR APPARATUS

2018 ◽  
Vol 7 (2) ◽  
pp. 38-49
Author(s):  
Yu. N. Odarenko ◽  
N. V. Rutkovskaya ◽  
S. G. Kokorin ◽  
A. N. Stasev ◽  
L. S. Barbarash
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Invasive Monitoring ◽  
Central Hemodynamics ◽  
Long Term Outcomes ◽  
Group 2 ◽  
Bioprosthetic Mitral Valve ◽  
Group 1

Aim. To assess the immediate and long-term outcomes after bioprosthetic mitral valve replacement with the preservation of the subvalvular apparatus. Methods. 304 patients who underwent primary bioprosthetic mitral valve replacement in the period from 2001 to 2009 were included in the study. Patients were enrolled into two groups with either preserved subvalvular structures (Group 1. n = 142, 47%) or resected structures (Group 2, n = 162) during bioprosthetic mitral valve replacement. For the unbiased assessment of the efficiency of valve-preserving approach, randomly selected patients from Group 1 (n = 75) and Group 2 (n = 40) underwent preoperative and postoperative invasive monitoring of the central hemodynamics using the Swan-Ganz thermodilution catheter. Results In-hospital mortality was 1.4% (n = 2) in Group 1 and 4.3% in Group 2. The most common cause of death was acute left ventricular failure. We found that the preservation of subvalvular structures allows ensuring the optimal linear and volumetric echocardiography parameters in the immediate postoperative period, despite the hemodynamic profile of the defect. However, the positive effects were more pronounced in patients with more severe mitral regurgitation. Patients with preserved subvalvular structures had more durable surgical mitral valve replacement according to the echocardiographic findings in the long-term period. The invasive monitoring of central hemodynamics allowed determining that total subvalvular apparatus preservation was associated with more significant pressure decline in the pulmonary circulation (mean pulmonary arterial pressure and pulmonary capillary wedge pressure) and improved cardiac index and output. Posterior leaflet preservation was associated with less pronounced changes and patients who underwent routine mitral valve replacement had the worst intermediate outcomes. Conclusion The results of the presented study suggest that the preservation of subvalvular apparatus, unless otherwise indicated, is associated with improved immediate and long-term outcomes after mitral valve replacement. 

Sign in / Sign up

Export Citation Format

Share Document